Pancreatic adenocarcinoma is a lethal condition with aincreasingfrequency, predicted to become the second prominent cause of cancer death in some regions. It frequently presents at an advanced stage, which contributes to poor five-year survival rates of 2%-9%, ranking firmly last amongst all cancer sites in terms of predictive outcomes for patients. Better understanding of the risk factors and symptoms accompanying with this disease is significant to advise both health professionals and the general population of potential preventive and/or early detection measures. The management of pancreatic adenocarcinoma is increasing, with the overview of new surgical approaches and medical treatments such as laparoscopic methods and neo-adjuvant chemoradiotherapy, though this has only led to modest developments in results.
https://maviyolculuk.online/
https://mavitur.online/
https://marmaristeknekirala.com.tr
https://tekneturumarmaris.com.tr
https://bodrumteknekirala.com.tr
https://gocekteknekirala.com.tr
https://fethiyeteknekirala.com.tr
Anupama Bulla
Journal of Clinical and Molecular Endocrinology received 120 citations as per google scholar report